tirzepatide and hormone replacement therapy New research from a Mayo Clinic–led study suggests that postmenopausal women using menopause may experience greater weight loss when treated with tirzepatide, a GLP-1–based medication for overweight obesity. In How Does Tirzepatide Work? |

Personalized interventions, such as tailored strength training programs or surgical options, can be developed to address these anatomical risk factors

doi: 10.1161/01.RES.0000256089.30318.20

Importantly, the GI AEs associated with semaglutide are frequent but should not overshadow its treatment benefits, especially considering the low incidence of thyroid cancer

We also recommend tracking progress through photos and measurements to keep you motivated and focused on long-term success

Inject outside that area, not right next to the belly button

Patients who inject before bed often report that appetite suppression feels less disruptive because they are not focusing on meal timing overnight